Clinical Trial

Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer

Name: Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer — clinical trial record (NCT07169916)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: YJ-BTC

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the impact of Yueju Pill on quality of life and treatment efficacy in patients with advanced biliary tract cancer (BTC) receiving standard therapy.

Trial Details

NCT Number	NCT07169916
Lead Sponsor	Fudan University Collaborators: Shanghai Zhongshan Hospital, Shanghai Geriatric Medical Center, Minhang Central Hospital, Xuhui Central Hospital, Shanghai
Conditions	Biliary Tract Cancer (BTC)
Enrollment	210 participants
Start Date	2025-09-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-09-12